PubMed COVID-19 Clinical Care

No abstract

In the wake of the unprecedented health crisis triggered by the global COVID-19 pandemic, countries are still grappling with the pandemic's immediate health and socioeconomic consequences. This paper presents an extended SEIRD model with vaccination

In this work, an electrochemical method was developed for rapid and sensitive detection of hydroxychloroquine (HCQ), an ineffective candidate drug for COVID-19 treatment however widely consumed during the pandemic, in aqueous samples using a multi

CONCLUSION: Clinical management of critical COVID-19 cases in Ethiopia is associated with a significant financial burden. Invasive intervention is unlikely to be a cost-effective COVID-19 intervention in Ethiopia compared to noninvasive critical case

Under the influence of the global COVID-19 pandemic, the demand for medical equipment and epidemic prevention materials has increased significantly, but the existing production lines are not flexible and efficient enough to dynamically adapt to

CONCLUSION: AMN may be an extremely rare adverse event of SARS-COV-2 vaccination, especially in patients with other risk factors.

Dengue virus infection, a highly prominent health concern, has caused many health complications, positive cases, and deaths in Bangladesh in previous years. However, the prevalence of this infection and fatality rates in 2022 has shattered all prior

CONCLUSIONS: These results suggest that identified circulating proteins may be useful for identifying COVID-19 patients with worse outcomes, and this potential utility may extend to other populations.

CONCLUSIONS: NRAMP-1 protein levels were significantly lower in COVID-19 patients who died and had comorbidities.

CONCLUSION: MSCs and their extracellular vesicles can significantly reduce the serum levels of inflammatory markers in COVID-19 patients, with no serious adverse events. Trial registration IRCT, IRCT registration number: IRCT20200217046526N2